| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.8M | +0.1% | -77.9% |
| Cost of Revenue | $1.4M | -10.9% | -82.0% |
| Gross Profit | $1.4M | +14.3% | -71.3% |
| R&D Expense | -$216K | -267.4% | -126.5% |
| SG&A Expense | $924K | -31.6% | -35.9% |
| Operating Income | -$1.8M | +44.9% | +27.0% |
| Pre-tax Income | -$2.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.2M | +450.0% | -72.9% |
| Accounts Receivable | $839K | -5.5% | -1.4% |
| Current Assets | $19.8M | +19.0% | -79.3% |
| Total Assets | $23.4M | +13.6% | -81.6% |
| Current Liabilities | $24.0M | -2.8% | -76.0% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.2M | — | — |
| Capital Expenditures | $76K | — | — |
| Investing Cash Flow | -$76.4M | — | — |
| Financing Cash Flow | $7.4M | — | — |
| Free Cash Flow | -$6.3M | — | — |
| +46.9% |
| +57.4% |
| Income Tax | $0 | -100.0% | -100.0% |
| Net Income | -$2.0M | +76.8% | +62.3% |
| EPS (Basic) | -$0.07 | +91.3% | +90.8% |
| EPS (Diluted) | -$0.07 | +91.3% | +90.8% |
| $26.6M |
| -3.3% |
| -78.0% |
| Stockholders' Equity | -$3.2M | +53.6% | -151.0% |